Annual Total Long Term Liabilities
$272.82 M
-$111.83 M-29.07%
31 December 2023
Summary:
Beam Therapeutics annual total long term liabilities is currently $272.82 million, with the most recent change of -$111.83 million (-29.07%) on 31 December 2023. During the last 3 years, it has risen by +$169.04 million (+162.89%). BEAM annual total long term liabilities is now -37.18% below its all-time high of $434.28 million, reached on 31 December 2021.BEAM Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$213.81 M
-$16.03 M-6.98%
30 September 2024
Summary:
Beam Therapeutics quarterly total long term liabilities is currently $213.81 million, with the most recent change of -$16.03 million (-6.98%) on 30 September 2024. Over the past year, it has dropped by -$77.42 million (-26.58%). BEAM quarterly long term liabilities is now -50.77% below its all-time high of $434.28 million, reached on 31 December 2021.BEAM Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BEAM Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -29.1% | -26.6% |
3 y3 years | +162.9% | +6.2% |
5 y5 years | +3588.3% | +793.7% |
BEAM Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -37.2% | +162.9% | -50.8% | +6.2% |
5 y | 5 years | -37.2% | +3588.3% | -50.8% | +793.7% |
alltime | all time | -37.2% | >+9999.0% | -50.8% | +2790.4% |
Beam Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $213.81 M(-7.0%) |
June 2024 | - | $229.84 M(-11.3%) |
Mar 2024 | - | $259.09 M(-5.0%) |
Dec 2023 | $272.82 M(-29.1%) | $272.82 M(-6.3%) |
Sept 2023 | - | $291.23 M(-12.5%) |
June 2023 | - | $332.71 M(-5.2%) |
Mar 2023 | - | $350.92 M(-8.8%) |
Dec 2022 | $384.64 M(-11.4%) | $384.64 M(-3.1%) |
Sept 2022 | - | $396.91 M(-2.2%) |
June 2022 | - | $405.94 M(+0.1%) |
Mar 2022 | - | $405.54 M(-6.6%) |
Dec 2021 | $434.28 M | $434.28 M(+115.7%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $201.35 M(-6.7%) |
June 2021 | - | $215.81 M(+27.9%) |
Mar 2021 | - | $168.73 M(+62.6%) |
Dec 2020 | $103.78 M(+298.9%) | $103.78 M(+237.5%) |
Sept 2020 | - | $30.75 M(+1.8%) |
June 2020 | - | $30.20 M(+1.3%) |
Mar 2020 | - | $29.80 M(+14.6%) |
Dec 2019 | $26.02 M(+251.7%) | $26.02 M(+8.7%) |
Sept 2019 | - | $23.92 M(+10.8%) |
June 2019 | - | $21.59 M(+191.8%) |
Dec 2018 | $7.40 M(>+9900.0%) | $7.40 M |
Dec 2017 | $20.00 K | - |
FAQ
- What is Beam Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Beam Therapeutics?
- What is Beam Therapeutics annual total long term liabilities year-on-year change?
- What is Beam Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Beam Therapeutics?
- What is Beam Therapeutics quarterly long term liabilities year-on-year change?
What is Beam Therapeutics annual total long term liabilities?
The current annual total long term liabilities of BEAM is $272.82 M
What is the all time high annual total long term liabilities for Beam Therapeutics?
Beam Therapeutics all-time high annual total long term liabilities is $434.28 M
What is Beam Therapeutics annual total long term liabilities year-on-year change?
Over the past year, BEAM annual total long term liabilities has changed by -$111.83 M (-29.07%)
What is Beam Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of BEAM is $213.81 M
What is the all time high quarterly long term liabilities for Beam Therapeutics?
Beam Therapeutics all-time high quarterly total long term liabilities is $434.28 M
What is Beam Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, BEAM quarterly total long term liabilities has changed by -$77.42 M (-26.58%)